Verifying…
Home / Drug A–Z / Rista H Tablet 50/12.5

Rista H Tablet 50/12.5

NAFDAC Reg. No. C4-1352 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Rista H Tablet 50/12.5
NAFDAC number
C4-1352
Active ingredient
Losartan Potassium; Hydrochlorothiazide
Strength
50 mg; 12.5 mg
Form
Tablet
Manufacturer
Not listed
Applicant (holder)
Dony-Triumph and Company Nigeria Limited
Approved
21 Dec 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
20 Dec 2025
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Rista H Tablet 50/12.5 is on the NAFDAC register with an active registration (C4-1352). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Rista H Tablet 50/12.5

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. …

How to take it and how often
  • Therapy should be individualized according to patient response
  • Use the smallest dosage necessary to achieve the required response
  • Adults For Edema - The usual adult dosage is 25 to 100 mg daily as a single or divided dose
  • Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week
  • With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur
  • For Control Of Hypertension - The usual initial dose
  • Adults is 25 mg daily given as a single dose
  • The dose may be increased to 50 mg daily, given as a single or two divided doses
  • Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS )
  • Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents
  • Infants and Children For Diuresis and For Control of Hypertension - The usual pediatric dosage is 0.5 to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in
  • Infants up to 2 years of age or 100 mg per day in
  • Children 2 to 12 years of age
  • Infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required (see PRECAUTIONS , Pediatric Use )
Children
  • There are no well-controlled clinical trials
  • Pediatric patients
  • Information on dosing in this age group is supported by evidence from empiric use
  • Pediatric patients and published literature regarding the treatment of hypertension in such patients. (See DOSAGE AND ADMINISTRATION , I nfants and Children )
While you are taking it

Non-melanoma Skin Cancer: Instruct patients taking hydrochlorothiazide to protect skin from the sun and undergo regular skin cancer screening.

Talk to a doctor first if
  • Anuria
  • Hypersensitivity to this product or to other sulfonamide-derived drugs
Medicines it may not mix with

When given concurrently the following drugs may interact with thiazide diuretics. Alcohol, Barbiturates, or Narcotics Potentiation of orthostatic hypotension may occur. Antidiabetic Drugs - (Oral Agents and Insulin) Dosage adjustment of the antidiabetic drug may be required. Other Antihypertensive Drugs Additive effect or potentiation. Cholestyramine and Colestipol Resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively. …

Warnings

Use with caution in severe renal disease. In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. Thiazides may add to or potentiate the action of other antihypertensive drugs. Sensitivity reactions may occur in patients with or without a history of allergy or bronchial asthma. The possibility of exacerbation or activation of systemic lupus erythematosus has been reported. …

Possible side effects

The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity. Body As A Whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia. Hematologic: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia. …

Pregnancy and breastfeeding

Pregnancy Teratogenic Effects: Studies in which hydrochlorothiazide was orally administered to pregnant mice and rats during their respective periods of major organogenesis at doses up to 3,000 and 1,000 mg hydrochlorothiazide/kg, respectively, provided no evidence of harm to the fetus. There are, however, no adequate and well-controlled studies in pregnant women. …

If you take too much

The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. In the event of overdosage, symptomatic and supportive measures should be employed. Emesis should be induced or gastric lavage performed. Correct dehydration, electrolyte imbalance, hepatic coma and hypotension by established procedures. If required, give oxygen or artificial respiration for respiratory impairment. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-12-25.

Label for losartan potassium and hydrochlorothiazide, the active ingredient registered with NAFDAC.

Check your pack of Rista H Tablet 50/12.5

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Rista H Tablet 50/12.5

What is in Rista H Tablet 50/12.5?

Rista H Tablet 50/12.5 contains Losartan Potassium; Hydrochlorothiazide (50 mg; 12.5 mg), as tablet, according to its NAFDAC registration record.

Is Rista H Tablet 50/12.5 registered with NAFDAC?

Yes. Rista H Tablet 50/12.5 is listed on the NAFDAC register under registration number C4-1352, and its registration is active as of 28 October 2026.

Has Rista H Tablet 50/12.5 been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Rista H Tablet 50/12.5 in our automatically synced alert list.

How can I check that my pack of Rista H Tablet 50/12.5 is genuine?

Run a free authenticity scan with the NAFDAC number C4-1352, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Rista H Tablet 50/12.5?

Follow your prescription or the leaflet in your pack. The official label says: Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Adults For Edema - The usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent s…

What is Rista H Tablet 50/12.5 used for?

Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in t (Summarised from the official U.S. FDA label for losartan potassium and hydrochlorothiazide. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Rista H Tablet 50/12.5? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.